CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

autologous lymphocytes

Cell therapyexperimental

Clinical trial activity

51 trials · 24 clinical orgs · 0 marketing orgs

Phase 1
33
Phase 2
23
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 1994 (NCT00002589)

Timeline

1990s

  1. Jan 1, 1994

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 1998

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • LymphocytesSupplementation

    supplementation - lymphocytes

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous lymphocytes

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03985033N/AJun 30, 2019The European Research Group on Periodontology (ERGOPerio), The University of Hong Kong
NCT03820310Phase 2Apr 30, 2019Chinese Academy of Medical Sciences, Newish Technology (Beijing) Co.,Ltd.
NCT02700841Phase 2May 1, 2016Emory University, OncoPep, Inc.
NCT01943188Phase 1May 1, 2014National Cancer Institute (NCI), Stanford University
NCT01653834N/AJul 1, 2012Johns Hopkins University
NCT01339663Phase 1Mar 1, 2012National Cancer Institute (NCI), University of Washington
NCT01106235Phase 1Apr 1, 2010National Cancer Institute (NCI), University of Washington
NCT00945269Phase 1/Phase 2 (Phase 2)Jul 1, 2009National Cancer Institute (NCI), University of Washington
NCT01005537N/AJun 1, 2009National Cancer Institute (NCI), University of Washington
NCT00566098Phase 1/Phase 2 (Phase 2)Nov 1, 2007Johns Hopkins University, National Cancer Institute (NCI)
NCT00562640Phase 1Oct 1, 2007Cornell University, National Cancer Institute (NCI)
NCT00553306Phase 1/Phase 2 (Phase 2)Sep 1, 2007University of Washington
NCT00512889Phase 1Aug 1, 2007Harvard University
NCT00020722Phase 2Aug 1, 2007National Cancer Institute (NCI), Wayne State University
NCT00621452Phase 1Aug 1, 2007National Cancer Institute (NCI), University of Washington
NCT00513604Phase 2Jun 1, 2007National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00466531Phase 1/Phase 2 (Phase 2)Mar 21, 2007Cornell University, National Cancer Institute (NCI)
NCT00438984Phase 1Dec 1, 2006National Cancer Institute (NCI), University of Washington
NCT00313508Phase 1Feb 1, 2006National Cancer Institute (NCI), University of South Florida
NCT00588913Phase 1/Phase 2 (Phase 2)Jan 1, 2006Tokyo Women's Medical University
Showing 20 of 51 trials
Page 1 / 3

Organizations

Research & Development (24)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government35631994
University of WashingtonAcademic/Hospital141431998
National Institutes of Health (NIH)Government6322004
Wayne State UniversityAcademic/Hospital6621997
Boston UniversityAcademic/Hospital2221998
City of Hope National Medical CenterAcademic/Hospital2222002
Cornell UniversityAcademic/Hospital2222007
Harvard UniversityAcademic/Hospital2111998
Johns Hopkins UniversityAcademic/Hospital2222007
University of MarylandAcademic/Hospital2211999
University of WisconsinAcademic/Hospital2111994
Case Western Reserve UniversityAcademic/Hospital1111999
Chinese Academy of Medical SciencesAcademic/Hospital1012019
Emory UniversityAcademic/Hospital1112016
Hoag Memorial Hospital PresbyterianAcademic/Hospital1111999
Newish Technology (Beijing) Co.,Ltd.Government1112019
OncoPep, Inc.For profit1012016
Pennsylvania State UniversityAcademic/Hospital1112004
Stanford UniversityAcademic/Hospital1112014
The European Research Group on Periodontology (ERGOPerio)Academic/Hospital1112019
24 organizations
Page 1 / 2